Prevention of Peritransplantation Viridans Streptococcal Bacteremia with Early Vancomycin Administration: A Single‐Center Observational Cohort Study | Zendy

Dana Jaffe | Zendy; Ann A. Jakubowski | Zendy; Kent A. Sepkowitz | Zendy; Rani Sebti | Zendy; Timothy E. Kiehn | Zendy; Eric G. Pamer | Zendy; Genovefa A. Papanicolaou | Zendy

Open Access

Prevention of Peritransplantation Viridans Streptococcal Bacteremia with Early Vancomycin Administration: A Single‐Center Observational Cohort Study

Author(s) -

Dana Jaffe,

Ann A. Jakubowski,

Kent A. Sepkowitz,

Rani Sebti,

Timothy E. Kiehn,

Eric G. Pamer,

Genovefa A. Papanicolaou

Publication year - 2004

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/425612

Subject(s) - medicine , vancomycin , hazard ratio , bacteremia , cohort , cumulative incidence , incidence (geometry) , cohort study , proportional hazards model , hematopoietic stem cell transplantation , transplantation , surgery , confidence interval , antibiotics , staphylococcus aureus , bacteria , microbiology and biotechnology , genetics , physics , optics , biology

Viridans streptococcal bacteremia (VSB) after allogeneic hematopoietic stem cell transplantation (HSCT) is associated with substantial mortality. Prevention of this serious complication is therefore a high priority. The objective of this study was to evaluate the effect of early vancomycin administration on rates and outcomes of VSB.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research